News

The novel Person-Centered Primary Care Measure has established 11 domains that each represent a single item representing the broad scope of primary care. The team behind it has created a measure that “actually aligns with the work of primary care physicians, and what matters to patients.”

Teens and adults had similar weight loss after gastric bypass surgery, but teens were more likely to experience remission of type 2 diabetes and hypertension than adults.

Dalteparin sodium injection was shown to result in VTE resolution in a majority of treated patients from a clinical trial.

Self-reported vision impairment was associated with a greater risk of developing depression and anxiety symptoms in patients 65 and older.

Metformin use associated with a 58% reduced risk of age-related macular degeneration (AMD) in a case-controlled retrospective study.

Patients on 2 different doses of the once-daily oral JAK1 inhibitor reached statistically significant measures for improved symptoms.

A recent study found that recreational cannabis legalization can lead to increase in car accidents and injuries, but decreases in chronic pain admissions.

Patients diagnosed with psoriasis face a nearly three-fold greater risk of developing anxiety disorders.

CompEx combines deteriorations and frequency of asthma exacerbations that are recorded twice daily by patients. An algorithm is developed based off of patient deterioration below threshold limits.

Investigators found that habitual glucosamine use was linked to lower risk of cardiovascular disease, coronary heart disease, and stroke.

Previous trials have sought out fracture risk between the therapies over 1 year, and have also found few differences.

A recent study from the Mayo Clinic found that tramadol carries a risk of long-term use similar to that of oxycodone and hydrocodone.

In the LIBERTY 1 study, daily relugolix combination therapy led to a reduction in menstrual blood loss of 84.3% and improvements in pain and quality of life.

Investigators found that patients with undiagnosed severe obstructive sleep apnea were at an increased risk of suffering a postoperative cardiovascular event.

Close to half of observed patients had severe asthma and uncontrolled even with high doses of ICS or LABA. Among them, more than half had the eosinophilic inflammatory phenotype.

Assaults have become common in emergency departments. Organizers and individuals are calling on caregivers and administrators to collaborate on real solutions.

Using education, EHR alerts, and increased clinic capacity, investigators increased HCV screening of baby boomers from 10.1% to 34.6%.

Machine Learning algorithm analyzes 85 individual variables to determine a person's risk of having a heart attack or death with more than 90% accuracy.

Aflibercept (Eylea) is an anti-VEGF treatment administered as an intravitreal injection.

Zebra Medical Vision received clearance for HealthPNX, an AI-based chest X-ray triage product.

The FDA has expanded the indication for incobotulinumtoxinA (Xeomin) to include treating blepharospasm (involuntary blinking) in adults.

The KardiaMobile 6L device is the first FDA-cleared 6-lead electrocardiogram (ECG) device for personal use.

Investigators found that 700 women suffer pregnancy-related deaths every year and 3 of every 5 pregnancy-related deaths were preventable.

Short-course, "post-exposure" direct-acting antivirals enabled successful transplantation of HCV-infected hearts and lungs to uninfected recipients.

Filters that break up the exhaust from diesel engines are intended to decrease the health impacts of heavy roadway traffic, but a new study suggests the opposite might be happening in some cases.

Despite less than 2% of patients receiving surgery, they accounted for more than 25% of total expenditures within 1 year of diagnosis.

Most surveyed comorbid patients reported they required the help of family, friends or caregivers during pneumonia recovery, and needed an average of 28 days of care.

A new test involving pediatric lung function shows that just 15% of patients will achieve strict remission in adulthood.

Currently, DAAs lack FDA approval for hepatitis C treatment in children under 12 years, but pediatricians call for their approval.

Patients with plaque psoriasis taking apremilast, etanercept, and ustekinumab had a lower rate of serious infections than those who took methotrexate.